We are live on ! Find out more
ONCS

OncoSec Medical

Delisted

ONCS was delisted on the 23rd of June, 2023.

20 hedge funds and large institutions have $1.57M invested in OncoSec Medical in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more capital inflows, than outflows

Capital inflows: $1.78M | Capital outflows: $643K

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0.69% more ownership

Funds ownership: 5.15% → 5.84% (+0.69%)

33% less funds holding

Funds holding: 30 → 20 (-10)

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
20
Holders Change
-10
Holders Change %
-33.33%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
3
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ONCS Hedge Fund Activity: Q2 2019 in Review

20 of the 4,627 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical (ONCS) for Q2 2019, worth a combined $1.57M — down 16% from $1.86M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ONCS and 7 opened new positions — a net loss of 10 holders — while 3 trimmed existing stakes and 6 added.

The largest buyer was 683 Capital Management, adding an estimated $691K. The largest seller was Intrinsic Edge Capital Management, exiting entirely with an estimated $280K sold.

  • 20 institutional investors held OncoSec Medical (ONCS) as of Q2 2019, down from 30 in Q1 2019.
  • Funds reported $1.57M of OncoSec Medical stock for Q2 2019, down 16% quarter-over-quarter.
  • 7 funds opened new OncoSec Medical positions in Q2 2019 and 17 closed out, a net change of -10 holders.
  • The largest OncoSec Medical buyer in Q2 2019 was 683 Capital Management, an estimated $691K added.
  • The largest OncoSec Medical seller in Q2 2019 was Intrinsic Edge Capital Management, an estimated $280K sold.

Based on aggregated 13F filings for Q2 2019.